Department of Cardiology, Arkansas Children's Hospital, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
The Lillie Frank Abercrombie Division of Cardiology, Texas Children's Hospital, Baylor College of Medicine, Houston, TX, USA.
Interv Cardiol Clin. 2024 Jul;13(3):319-331. doi: 10.1016/j.iccl.2024.03.005. Epub 2024 Apr 16.
With the improvement in the detection of congenital heart disease in fetal life, fetal cardiac interventions are pushing the envelope in hopes of either altering the natural history of disease or improving survival in certain high-risk lesions. These interventions include fetal aortic valvuloplasty for evolving hypoplastic left heart syndrome, fetal atrial septoplasty with or without atrial septal stenting for hypoplastic left heart syndrome and variants with intact or severely restrictive atrial septum, and fetal pulmonary valvuloplasty for severe pulmonary stenosis or pulmonary atresia with intact ventricular septum. This review discusses their indications, technical aspects, and outcomes based on available literature.
随着胎儿期先天性心脏病检测水平的提高,胎儿心脏介入治疗正在不断推陈出新,以期改变疾病的自然病程或提高某些高危病变的生存率。这些干预措施包括对进行性左心发育不良综合征进行胎儿主动脉瓣成形术、对左心发育不良综合征和伴有完整或严重限制型房间隔的各种变异型进行胎儿房间隔造口术和/或房间隔支架置入术、以及对严重肺动脉瓣狭窄或伴完整室间隔的肺动脉闭锁进行胎儿肺动脉瓣成形术。这篇综述根据现有文献讨论了这些介入治疗的适应证、技术要点和结果。